Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ALX Oncology Holdings Inc.(ALXO) | 9,699,925 | 9,699,925 | 0 | $144.43M | $108.15M | 38.37% | -$36.28M |
| Pharvaris N V COM | 4,919,504 | 4,289,304 | -630,200 | $137.99M | $99.13M | 35.17% | -$38.87M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 1,035,396 | 1,035,396 | 0 | $33.44M | $34.77M | 12.33% | +$1.33M |
| Acelyrin Inc | 3,852,470 | 3,852,470 | 0 | $28.74M | $26.00M | 9.23% | -$2.74M |
| Elevation Oncology Inc | 2,914,255 | 2,696,133 | -218,122 | $1.56M | $13.83M | 4.91% | +$12.27M |
| IMPEL PHARMACEUTICALS INCCOM | 2,759,791 | 0 | -2,759,791 | $340.8K | $0 | — | -$340.8K |
| RAYZEBIO INCCOM | 5,158,162 | 0 | -5,158,162 | $320.68M | $0 | — | -$320.68M |